© 2004 by European Society of Cardiology
Copyright © 2004, European Society of Cardiology
Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo
aCenter for Molecular Genetics, Department of Molecular Cardiology, Lerner Research Institute, The Cleveland Clinic Foundation, Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 44195, USA
bCenter for Cardiovascular Genetics, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
cThe Heart & Vascular Research Center, MetroHealth Campus, Case Western Reserve University, Cleveland, OH 44109, USA
dDepartment of Biology, Cleveland State University, Cleveland, OH 44114, USA
eSection of Electrophysiology and Pacing, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
* Corresponding author. Center for Molecular Genetics, Lerner Research Institute, ND4-38, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA. Tel.: +1-216-4450570; fax: +1-216-4442682. wangq2{at}ccf.org
Objective: Mutations in the cardiac sodium channel gene SCN5A are responsible for type-3 long QT disease (LQT3). The genesis of cardiac arrhythmias in LQT3 is multifaceted, and the aim of this study was to further explore mechanisms by which SCN5A mutations lead to arrhythmogenesis in vivo. Methods: We engineered selective cardiac expression of a long QT syndrome (LQTS) mutation (N1325S) in human SCN5A and generated a transgenic mouse model, TGM(NS31). Results: Conscious and unrestrained TGM(NS31)L12 mice demonstrated a significant prolongation of the QT-interval and a high incidence of spontaneous polymorphic ventricular tachycardia (VT) and fibrillation (VF), often resulting in sudden cardiac death (n = 52:156). Arrhythmias were suppressed by mexiletine, a sodium channel blocker for the late persistent sodium current. Action potentials (APs) from TGM(NS31)L12 ventricular myocytes exhibited early afterdepolarizations and longer 90% AP durations (APD90=69±5.9 ms) than control (APD90=46.7±4.8 ms). Voltage-clamp experiments in transgenic myocytes revealed a peak inward sodium current (INa) followed by a slow recovery from inactivation. After mexiletine application, transgenic ventricular APDs were shortened, and recovery from inactivation of INa was enhanced. These suggest that the N1325S transgene is responsible for the abnormal signals present in transgenic cells as well as the genesis of lethal arrhythmias in mice. Interestingly, transgenic but not wild-type myocytes displayed longer APDs with a shortening of CLs. Conclusions: Our findings show that a new model for LQTS has been established, and we report on an arrhythmogenic mechanism that, unlike other SCN5A mutations, results in poor restitution of APD with increasing rate as a possible substrate for arrhythmogenesis.
KEYWORDS Cardiac sodium channel SCN5A; Long QT syndrome; Late persistent sodium current; Arrhythmia mechanisms; Sudden death
Time for primary review 16 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Fan, Q. Chen, and Q. K. Wang Functional Role of Transcriptional Factor TBX5 in Pre-mRNA Splicing and Holt-Oram Syndrome via Association with SC35 J. Biol. Chem., September 18, 2009; 284(38): 25653 - 25663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Zakon, D. J. Zwickl, Y. Lu, and D. M. Hillis Molecular evolution of communication signals in electric fish J. Exp. Biol., June 1, 2008; 211(11): 1814 - 1818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Song, J. C. Shryock, and L. Belardinelli An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2031 - H2039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wu, S. L. Yong, C. Fan, Y. Ni, S. Yoo, T. Zhang, X. Zhang, C. A. Obejero-Paz, H.-J. Rho, T. Ke, et al. Identification of a New Co-factor, MOG1, Required for the Full Function of Cardiac Sodium Channel Nav1.5 J. Biol. Chem., March 14, 2008; 283(11): 6968 - 6978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Abriel Roles and regulation of the cardiac sodium channel Nav1.5: Recent insights from experimental studies Cardiovasc Res, December 1, 2007; 76(3): 381 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. D. J. ter Keurs and P. A. Boyden Calcium and Arrhythmogenesis Physiol Rev, April 1, 2007; 87(2): 457 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Vecchietti, E. Grandi, S. Severi, I. Rivolta, C. Napolitano, S. G. Priori, and S. Cavalcanti In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H56 - H65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Zakon, Y. Lu, D. J. Zwickl, and D. M. Hillis Sodium channel genes and the evolution of diversity in communication signals of electric fishes: Convergent molecular evolution PNAS, March 7, 2006; 103(10): 3675 - 3680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Md. S. Amran, K. Hashimoto, and N. Homma Effects of Sodium-Calcium Exchange Inhibitors, KB-R7943 and SEA0400, on Aconitine-Induced Arrhythmias in Guinea Pigs in Vivo, in Vitro, and in Computer Simulation Studies J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 83 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q Wang, S Chen, Q Chen, X Wan, J Shen, G A Hoeltge, A A Timur, M T Keating, and G E Kirsch The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel J. Med. Genet., May 1, 2004; 41(5): e66 - e66. [Full Text] [PDF]
|
|
|
|
|
|
C. Napolitano Transgenic models in cardiac arrhythmias: how close can we get to the bedside? Cardiovasc Res, February 1, 2004; 61(2): 206 - 207. [Full Text] [PDF]
|
|